Development of a Personalized Discussion Prioritization Tool for Older Adults Considering Adjuvant Chemotherapy for Breast Cancer

NCT05073432 | Completed Results DMC

• 1 other identifier: UCCS20110
• Study Type: interventional
• Target: 10
• Locations: 1 country
• Sites: 1

Brief Summary

The investigators have developed a Discussion Prioritization Tool (DPT) for older adults consider adjuvant chemotherapy that utilizes Conjoint Analysis (CA) methodology and the objective of the current study is to assess usability of this DPT in the target population, older adults with breast cancer and to adapt the tool to optimize usability for the target population.

Conditions

Breast Cancer

Keywords

Breast Cancer; Discussion Prioritization Tool (DPT)

Outcome Measures

Primary Outcomes (1)

• Functional Assessment of the Discussion Prioritization Tool (DPT)

  System Usability Scale (SUS) (score on a 10-item scale, with a total score ranging from 0-100; a higher score corresponds to greater usability). We will deem the tool usable if our mean SUS score among the 10 patients enrolled is \>68.

  2 Months

Study Arms (1)

Experimental

EXPERIMENTAL

Electronic completion of Geriatric Assessment and Conjoint Analysis with result output.

Other: Experimental

Interventions

Experimental OTHER

Usability of the Discussion Prioritization Tool (DPT) by completing Geriatric Assessment and Conjoint Analysis

Experimental

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• Age ≥65
• Diagnosis of stage I-III BC
• Being considered for adjuvant chemotherapy
• Able to speak and read English
• Able to participate in study procedures.

You may not qualify if:

• Lacking medical decision-making capacity as determined by their oncologist
• Evidence of metastatic disease

Sponsors & Collaborators

• University of Rochester: lead

Study Sites (1)

University of Rochester

Rochester, New York, 14642, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Results Point of Contact

• Title: Dr. Allison Magnuson
• Organization: University of Rochester

allison_magnuson@urmc.rochester.edu

585-602-5085

Study Officials

• Allison Magnuson, DO

  Univ. of Rochester Wilmot Cancer Center

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor - Department of Medicine , Hematology/Oncology (SMD)

Study Record Dates

• First Submitted: September 28, 2021
• First Posted: October 11, 2021
• Study Start: July 28, 2021
• Primary Completion: March 15, 2023
• Study Completion: March 15, 2023
• Last Updated: April 27, 2025
• Results First Posted: October 15, 2024

Record last verified: 2025-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)